TetraGraph for Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the necessary dosage of rocuronium during surgeries using the TetraGraph Neuromuscular Transmission Monitor, a device that measures muscle response. It focuses on children undergoing surgery who require this drug for muscle relaxation. Suitable candidates for this trial are those under 18, undergoing surgery with general anesthesia, and needing continuous rocuronium.
As an unphased trial, participation offers an opportunity to contribute to important research that could enhance surgical care for children.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the TetraGraph Neuromuscular Transmission Monitor is safe for use in surgical procedures for patients under 18?
Research has shown that TetraGraph helps doctors make better decisions and keeps patients safer during surgeries. It effectively monitors neuromuscular blockade, which prevents movement during surgery. Evidence confirms that TetraGraph aids doctors in making safer choices during operations.
Rocuronium, a drug commonly used in surgeries to relax muscles, is well-tolerated and has undergone sufficient testing to establish its safety in humans.
Overall, both TetraGraph and rocuronium are considered safe and effective for use in surgeries, providing reassurance about their safety in the operating room.12345Why are researchers excited about this trial?
The TetraGraph device is unique because it offers a cutting-edge solution for monitoring neuromuscular function during surgeries involving rocuronium infusion. Unlike traditional methods that rely on subjective assessments, TetraGraph provides objective, quantitative data on muscle response, potentially leading to more precise dosing and improved patient safety. Researchers are excited about this technology because it could enhance the accuracy of neuromuscular blockade management, reducing the risk of complications and speeding up recovery times for patients undergoing surgery.
What evidence suggests that the TetraGraph Neuromuscular Transmission Monitor is effective for surgical procedures in patients under 18?
Research has shown that the TetraGraph Neuromuscular Transmission Monitor accurately checks muscle relaxation during surgery, surpassing the precision of other devices. In this trial, the TetraGraph system will monitor patients receiving a continuous infusion of the neuromuscular blocking agent rocuronium. The system employs train-of-four (TOF) monitoring to provide reliable feedback from the onset of muscle relaxation to recovery. This assists doctors in better controlling medications like rocuronium, which relax muscles during surgery. Overall, the TetraGraph has proven to be highly accurate, making it a trusted tool in surgical procedures.14678
Are You a Good Fit for This Trial?
This clinical trial is for patients under 18 years old who are undergoing surgical procedures and will be monitored using the TetraGraph Neuromuscular Transmission Monitor. Specific inclusion and exclusion criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive rocuronium infusion during surgical procedures while being monitored using the TetraGraph Neuromuscular Transmission Monitor
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- TetraGraph
Find a Clinic Near You
Who Is Running the Clinical Trial?
Joseph D. Tobias
Lead Sponsor